European Study of Prostate Cancer Screening — 23-Year Follow-up

Long-term follow-up confirms a sustained reduction in deaths from prostate cancer with PSA testing, alongside an improved harm-benefit ratio. Future screening strategies should adopt risk-based approaches to minimize overdiagnosis while maintaining clinical benefits. (Funded by the Dutch Cancer Society and others; ERSPC ISRCTN registry number, ISRCTN49127736.).

Authors

Institutions

Publication Details

Journal
New England Journal of Medicine
Published
2025-10-29
DOI
https://doi.org/10.1056/nejmoa2503223
Citations
35
Primary Topic
Prostate Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
53.14
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

European Study of Prostate Cancer Screening — 23-Year Follow-up

Teuvo L.J. Tammela, G. Poinas, Kirsi Talala, Jonas Hugosson et al.
35 citations
New England Journal of Medicine
Prostate Cancer Diagnosis and Treatment
53.14
article

European Study of Prostate Cancer Screening — 23-Year Follow-up

Teuvo L.J. Tammela, G. Poinas, Kirsi Talala, Jonas Hugosson, Giuseppe Gorini, Sebastiaan Remmers, Anssi Auvinen, Marco Zappa, Rebecka Arnsrud Godtman, Monique J. Roobol, Stephen Wyler, Vera Nelen, Arnauld Villers, Ivo I. de Vos, Marianne Månsson, Donella Puliti, M. Luján, Maciej Kwiatkowski, Franz Recker, Chris H. Bangma, Fritz H. Schröder, Elly Den Hond, Álvaro Páez
article en
35 citations

Abstract

Long-term follow-up confirms a sustained reduction in deaths from prostate cancer with PSA testing, alongside an improved harm-benefit ratio. Future screening strategies should adopt risk-based approaches to minimize overdiagnosis while maintaining clinical benefits. (Funded by the Dutch Cancer Society and others; ERSPC ISRCTN registry number, ISRCTN49127736.).

New England Journal of MedicineVol. 393(17)
Tampere University of Applied Sciences (FI), Tampere University (FI), University of Basel (CH), Provincial Institute for Hygiene (BE), Clinique du Millénaire (FR), Klinikum Braunschweig (DE), Tampere University Hospital (FI), Tampere University (FI), Hospital Universitario de Fuenlabrada (ES), Cancer Society of Finland (FI), Erasmus MC Cancer Institute (NL), Kantonsspital Aarau (CH), Hospital Universitario Infanta Cristina (ES), Université Lille Nord de France (FR), University of Gothenburg (SE)
Openalex Percentile: Top 0%
Prostate Cancer Diagnosis and Treatment
53.14
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.